Progeny 3, Inc.
Progeny 3, Inc. reported 29 US-listed holdings worth $1.94 billion in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Cameco Corp. (12.4%), Interactive Brokers Group, Inc. (9.9%) and APi Group Corp. (7.7%). Against the quarter before, it opened 2 positions, added to 8, trimmed 2 and sold out of 5.
Reported holdings$1.94B+3.6% on Q1 2026
Positions29-3 on Q1 2026
The largest ten60.6%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Added toHeld
The 14 largest of its 29 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Opened 2Added 8Held 17Trimmed 2Sold out 5
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 2
- Archrock, Inc. AROC$42.4 million
- Ascendis Pharma A/s ASND$1.4 million
Added to 8
- Pool Corp. POOL+130,000 shares · +93%
- Cellebrite Di Ltd CLBT+871,871 shares · +77%
- Amazon.com Inc. AMZN+20,500 shares · +8%
- Ss&c Technologies Hldgs Inc. SSNC+74,000 shares · +6%
- Cameco Corp. CCJ+20,000 shares · +1%
- Acuren Corporation TIC+239,885 shares · +2%
- Alliance Resource Partners L ARLP+18,500 shares · +1%
- Enterprise Products Partners LP EPD+2,500 shares · +0%
Trimmed 2
- Natural Resource Partners L NRP-83,060 shares · -27%
- Par Technology Corp. PAR-46,750 shares · -2%
Sold out of 5
- GFL Environmental Inc. GFL$80.8 million last quarter
- Abivax SA ABVX$1.4 million last quarter
- Vaxcyte Inc. PCVX$1.4 million last quarter
- Ascendis Pharma A/s ASND$1.2 million last quarter
- Crinetics Pharmaceuticals in CRNX$871,680 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Cameco Corp. CCJ | 2,367,131 | $241.1 million | 12.44% | +20,000 |
| Interactive Brokers Group, Inc. IBKR | 2,195,640 | $191.1 million | 9.86% | no change |
| APi Group Corp. APG | 3,540,787 | $150.0 million | 7.74% | no change |
| Acuren Corporation TIC | 15,562,990 | $125.9 million | 6.50% | +239,885 |
| iShares Core S&P 500 ETF IVV | 139,069 | $104.1 million | 5.37% | no change |
| Ss&c Technologies Hldgs Inc. SSNC | 1,332,900 | $82.7 million | 4.27% | +74,000 |
| Alliance Resource Partners L ARLP | 3,248,264 | $77.9 million | 4.02% | +18,500 |
| Vanguard S&P 500 VOO | 103,300 | $70.9 million | 3.66% | no change |
| Martin Marietta Materials Inc. MLM | 113,150 | $65.3 million | 3.37% | no change |
| Solstice Advanced Materials Inc. SOLS | 731,100 | $64.8 million | 3.34% | no change |
| Amazon.com Inc. AMZN | 270,600 | $64.5 million | 3.33% | +20,500 |
| Enterprise Products Partners LP EPD | 1,686,131 | $62.0 million | 3.20% | +2,500 |
| Pool Corp. POOL | 270,000 | $58.0 million | 2.99% | +130,000 |
| Mplx LP MPLX | 1,015,966 | $57.2 million | 2.95% | no change |
| Daktronics Inc. DAKT | 2,746,408 | $53.7 million | 2.77% | no change |
| EQT Corp. EQT | 1,009,400 | $53.7 million | 2.77% | no change |
| Pricesmart Inc. PSMT | 272,100 | $53.2 million | 2.74% | no change |
| Energy Transfer LP ET | 2,743,907 | $52.5 million | 2.71% | no change |
| Agnico Eagle Mines Ltd AEM | 284,925 | $44.2 million | 2.28% | no change |
| Sixth Street Specialty Lendi TSLX | 2,476,398 | $42.5 million | 2.19% | no change |
| Archrock, Inc. AROC | 1,041,625 | $42.4 million | 2.19% | new |
| Ares Capital Corp. ARCC | 2,224,728 | $41.2 million | 2.13% | no change |
| Par Technology Corp. PAR | 2,124,058 | $37.0 million | 1.91% | -46,750 |
| Cellebrite Di Ltd CLBT | 2,000,000 | $29.2 million | 1.51% | +871,871 |
| Berkshire Hathaway Inc. Class B BRKB | 53,239 | $26.6 million | 1.37% | no change |
| Natural Resource Partners L NRP | 229,463 | $22.3 million | 1.15% | -83,060 |
| Blackstone Secd Lending FD BXSL | 772,156 | $18.3 million | 0.94% | no change |
| Warrior Met Coal, Inc. HCC | 54,235 | $4.4 million | 0.23% | no change |
| Ascendis Pharma A/s ASND | 5,230 | $1.4 million | 0.07% | new |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.